198 related articles for article (PubMed ID: 34744706)
1. Tetrathiomolybdate Treatment Attenuates Bleomycin-Induced Angiogenesis and Lung Pathology in a Sheep Model of Pulmonary Fibrosis.
Derseh HB; Perera KUE; Dewage SNV; Stent A; Koumoundouros E; Organ L; Pagel CN; Snibson KJ
Front Pharmacol; 2021; 12():700902. PubMed ID: 34744706
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis.
Organ L; Bacci B; Koumoundouros E; Barcham G; Milne M; Kimpton W; Samuel C; Snibson K
BMC Pulm Med; 2015 Jul; 15():81. PubMed ID: 26227819
[TBL] [Abstract][Full Text] [Related]
3. Small airway remodeling in a sheep model of bleomycin-induced pulmonary fibrosis.
Derseh HB; Dewage SNV; Perera UE; Koumoundouros E; Pagel CN; Organ L; Snibson KJ
Exp Lung Res; 2020 Dec; 46(10):409-419. PubMed ID: 34346276
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of pinocembrin in a sheep model of bleomycin-induced pulmonary fibrosis.
Derseh HB; Goodger JQD; Scheerlinck JY; Samuel CS; Woodrow IE; Palombo EA; Cumming A; Snibson K
PLoS One; 2021; 16(12):e0260719. PubMed ID: 34855848
[TBL] [Abstract][Full Text] [Related]
5. A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep.
Organ L; Bacci B; Koumoundouros E; Barcham G; Kimpton W; Nowell CJ; Samuel C; Snibson K
Exp Lung Res; 2015 Apr; 41(3):115-34. PubMed ID: 25531791
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis.
Brewer GJ; Dick R; Ullenbruch MR; Jin H; Phan SH
J Inorg Biochem; 2004 Dec; 98(12):2160-7. PubMed ID: 15541506
[TBL] [Abstract][Full Text] [Related]
7. K
Derseh HB; Dewage SNV; Perera KUE; Pagel CN; Koumoundouros E; Organ L; Snibson KJ
Sci Rep; 2019 Dec; 9(1):19893. PubMed ID: 31882807
[TBL] [Abstract][Full Text] [Related]
8. Comparative Study of Ectopic Lymphoid Aggregates in Sheep and Murine Models of Bleomycin-Induced Pulmonary Fibrosis.
Perera UE; Organ L; Royce SG; Samuel CS; Derseh HB; Dewage SNV; Koumoundouros E; Stent A; Snibson KJ
Can Respir J; 2023; 2023():1522593. PubMed ID: 36710924
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of pirfenidone in a sheep model of pulmonary fibrosis.
Dewage SNV; Organ L; Koumoundouros E; Derseh HB; Perera KUE; Samuel CS; Stent AW; Snibson KJ
Exp Lung Res; 2019; 45(9-10):310-322. PubMed ID: 31762329
[TBL] [Abstract][Full Text] [Related]
10. Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage.
Garcia O; Carraro G; Turcatel G; Hall M; Sedrakyan S; Roche T; Buckley S; Driscoll B; Perin L; Warburton D
PLoS One; 2013; 8(8):e71679. PubMed ID: 23967234
[TBL] [Abstract][Full Text] [Related]
11. Orotracheal treprostinil administration attenuates bleomycin-induced lung injury, vascular remodeling, and fibrosis in mice.
Nikitopoulou I; Manitsopoulos N; Kotanidou A; Tian X; Petrovic A; Magkou C; Ninou I; Aidinis V; Schermuly RT; Kosanovic D; Orfanos SE
Pulm Circ; 2019; 9(4):2045894019881954. PubMed ID: 31819797
[TBL] [Abstract][Full Text] [Related]
12. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
13. Insights into Disease Progression of Translational Preclinical Rat Model of Interstitial Pulmonary Fibrosis through Endpoint Analysis.
Kadam AH; Schnitzer JE
Cells; 2024 Mar; 13(6):. PubMed ID: 38534359
[TBL] [Abstract][Full Text] [Related]
14. Kallistatin protects against bleomycin-induced idiopathic pulmonary fibrosis by inhibiting angiogenesis and inflammation.
Huang X; Wang X; Xie X; Zeng S; Li Z; Xu X; Yang H; Qiu F; Lin J; Diao Y
Am J Transl Res; 2017; 9(3):999-1011. PubMed ID: 28386328
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the K
Organ L; Bacci B; Koumoundouros E; Kimpton WG; Samuel CS; Nowell CJ; Bradding P; Roach KM; Westall G; Jaffar J; Snibson KJ
Am J Respir Cell Mol Biol; 2017 Apr; 56(4):539-550. PubMed ID: 28060543
[TBL] [Abstract][Full Text] [Related]
16. The copper chelator tetrathiomolybdate regressed bleomycin-induced pulmonary fibrosis in mice, by reducing lysyl oxidase expressions.
Ovet H; Oztay F
Biol Trace Elem Res; 2014 Dec; 162(1-3):189-99. PubMed ID: 25349139
[TBL] [Abstract][Full Text] [Related]
17. The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis : Cilengitide and Bleomycin-Induced Pulmonary Fibrosis.
Ritzenthaler JD; Zhang M; Torres-Gonzalez E; Roman J
Lung; 2020 Dec; 198(6):947-955. PubMed ID: 33146772
[TBL] [Abstract][Full Text] [Related]
18. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling.
Burdick MD; Murray LA; Keane MP; Xue YY; Zisman DA; Belperio JA; Strieter RM
Am J Respir Crit Care Med; 2005 Feb; 171(3):261-8. PubMed ID: 15502109
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology Study of the Multiple Angiogenesis Inhibitor RC28-E on Anti-Fibrosis in a Chemically Induced Lung Injury Model.
Kou X; Sun Y; Li S; Bian W; Liu Z; Zhang D; Jiang J
Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31652997
[TBL] [Abstract][Full Text] [Related]
20. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
